Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
zedenoleucel (MT-401)
i
Other names:
MT-401, multi-antigen targeted autologous cytotoxic T cell therapy for AML, MultiTAA T cell therapy for AML
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Marker Therap
Drug class:
T lymphocyte replacement
Related drugs:
‹
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
lifileucel (1)
ATL 001 (0)
BNT221 (0)
C-TCR055 (0)
CYAD-01 (0)
CoTIL-01 (0)
H3.3K27M TCR T cell therapy (0)
IOV-2001 (0)
NeoTCR-P1 (0)
OBX-115 (0)
RAPA-201 (0)
allodepleted T-cell immunotherapeutics (0)
ThisCART22 (0)
UTIL-01 (0)
anti-KRAS G12D mTCR PBL (0)
marrow infiltrating lymphocytes (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login